| SECTOR | INDUSTRY |
| Health Care | Biotechnology |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
Cynthia McLaughlin
Cynthia McLaughlin
Cynthia McLaughlin
Jenna Brashear
| Share Statistics | CELZ | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $8.6 | $286.3 | 6% |
|
| Shares Out (Mil) | 3.7 | 54.2 | 11% |
|
| Institutional Ownership | 97.8% | 92.8% | 76% |
|
| Float (Mil) | 6.6 | 39.7 | 15% |
|
| Beta | 1.94 | 0.94 | 92% |
|
| Avg Daily Volume (000s) | 8,529 | 534 | 96% |
|
| Price Change (52-week) |
(59.8%) | 58.7% | 11% |
|
| Growth | CELZ | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 13.6% | na |
|
| Net Income (5yr) | 30.2% | (10.1%) | 85% |
|
| EPS (5yr) | 66.8% | 16.0% | 97 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 27.1% | (15.6%) | 84% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | 1 | 1 | |
| Current EPS | ($0.240) | ($1.180) | ($0.880) | |
| Month Ago EPS | ($0.230) | ($1.140) | ($0.860) | |
| # Rev Up | 0 | 0 | 0 | |
| # Rev Down | 1 | 1 | 1 | |
| Three Months Ago EPS | ($0.400) | ($1.570) | ($1.510) | |
| Year/Year Chg | (41.2%) | (53.1%) | (66.2%) | |
| Financials | CELZ | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $37 | na |
|
| Net Income (TTM) (Mil) | ($6) | ($43) | 32% |
|
| EPS (TTM) | ($1.953) | ($1.400) | 14% |
|
| Operating Cash Flow (TTM) (Mil) | ($6) | ($31) | 24% |
|
| Net Cash Flow (TTM) (Mil) | na | $2 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $4 | 0% |
|
| Enterprise Value (Q1) (Mil) | ($1) | $160 | 3% |
|
| Valuation | CELZ | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.98 | 2.77 | 21% |
|
| P/E | na | 19.1 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.0 | na |
|
| Ratios | CELZ | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 66.9% | 64.2% | 78% |
|
| Net Margin | na | (75.9%) | na |
|
| ROA | (73.3%) | (47.3%) | 8% |
|
| ROE | (78.0%) | (55.0%) | 11% |
|
| Liabilities to Assets | 7.4% | 29.6% | 4% |
|
| F-Score | 2 | 2 | 7% |
|
Creative Medical Technology Holdings, Inc. did not pass any screens on 8/20/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
